JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M602064200 on April 24, 2006

J. Biol. Chem., Vol. 281, Issue 29, 19892-19898, July 21, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/29/19892    most recent
M602064200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Litvan, J.
Right arrow Articles by Ridge, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litvan, J.
Right arrow Articles by Ridge, K. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

beta-Adrenergic Receptor Stimulation and Adenoviral Overexpression of Superoxide Dismutase Prevent the Hypoxia-mediated Decrease in Na,K-ATPase and Alveolar Fluid Reabsorption*

Juan Litvan{ddagger}, Arturo Briva{ddagger}, Mindy S. Wilson{ddagger}, G. R. Scott Budinger{ddagger}, Jacob Iasha Sznajder{ddagger}, and Karen M. Ridge{ddagger}§1

From the {ddagger}Division of Pulmonary and Critical Care Medicine, Northwestern University Medical School and §Medical Service, Veterans Affairs-Chicago Health Care System, Chicago, Illinois 60611

Received for publication, March 3, 2006 , and in revised form, April 20, 2006.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Hypoxia has been shown to cause lung edema and impair lung edema clearance. In the present study, we exposed isolated rat lungs to pO2 = 40 mm Hg for 60 min or rats to 8% O2 for up to 24 h and then measured changes in alveolar fluid reabsorption (AFR) and Na,K-ATPase function. Low levels of oxygen severely impaired AFR in both ex vivo and in vivo models. The decrease in AFR was associated with a decrease in Na,K-ATPase activity and protein abundance in the basolateral membranes from peripheral lung tissue of hypoxic rats. beta-Adrenergic agonists restored AFR in rats exposed to 8% O2 (from 0.02 ± 0.07 ml/h to 0.59 ± 0.03 ml/h), which was associated with parallel increases in Na,K-ATPase protein abundance in the basolateral membrane. Hypoxia is associated with increased production of reactive oxygen species. Therefore, we examined whether overexpression of SOD2, manganese superoxide dismutase, would prevent the hypoxia-mediated decrease in AFR. Spontaneously breathing rats were infected with a replication-deficient human type 5 adenovirus containing cDNA for SOD2. An otherwise identical virus that contained no cDNA was used as a control (Adnull). Hypoxic Adnull rats had decreased rates of AFR (0.12 ± 0.1 ml/h) as compared with hypoxic AdSOD2 and normoxic control rats (0.47 ± 0.04 ml/h and 0.49 ± 0.02 ml/h, respectively), with parallel changes in Na,K-ATPase.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Severe hypoxia can occur during ascent to high altitude (1) and in patients with acute respiratory distress syndrome and pulmonary edema. One of the primary defense mechanisms in the lung against alveolar fluid accumulation is the active transport of sodium out of the air spaces, which generates a transepithelial osmotic gradient that leads to alveolar fluid reabsorption (AFR).2 Sodium enters the apical membrane of alveolar epithelial cells through amiloride-sensitive Na+ channels (2, 3) and is then transported out across the basolateral membrane by the ouabain-inhibitable Na,K-ATPase (4–7). Hypoxia has been shown to impair AFR and may contribute to alveolar fluid accumulation (8, 9). However, the mechanisms by which hypoxia impairs AFR and alveolar epithelial sodium transport proteins has not been fully elucidated.

A mechanism by which hypoxia might impair AFR is by altering the function of either apical epithelial sodium channels and/or basolateral Na,K-ATPase proteins. Several in vitro studies using cultured alveolar epithelial cells have demonstrated that exposure to hypoxia results in the decrease in epithelial sodium channels and Na,K-ATPase protein abundance (10–12), which was reversed upon reoxygenation. Other investigators have reported various mechanisms associated with the decrease in alveolar fluid reabsorption in animals exposed to hypoxia in vivo (9, 11, 13).

In the current study, we provide evidence that exposure to hypoxia results in decreased Na,K-ATPase activity and protein abundance at the plasma membrane, which contributes to a decrease in alveolar fluid reabsorption in both in vivo and ex vivo models of hypoxia. These data suggest that (a) hypoxia decreases Na,K-ATPase activity by promoting the endocytosis of the Na,K-ATPase molecules, which is associated with a decrease in alveolar fluid reabsorption, (b) treatment with the beta-adrenergic receptor agonist, isoproterenol, recruits functional Na,K-ATPase molecules to the plasma membrane following exposure to hypoxia and restores alveolar fluid reabsorption in rat lungs, and (c) overexpression of the reactive oxygen species scavenger, SOD2, prevents the hypoxia-mediated decrease in alveolar fluid reabsorption and Na,K-ATPase function.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Isolated Perfused Lungs—The isolated perfused lung preparation used in our laboratory has been described (4). Briefly, lungs were isolated from anesthetized rats (65 mg/kg Nembutal, intraperitoneal) following a 10-min ventilation with 100% O2. The pulmonary artery and left atrial appendage were cannulated and perfused with a solution of 3% bovine serum albumin in buffered physiological salt solution. Fluorescein isothiocyanate (FITC)-labeled albumin was added to the perfusate to monitor leakage of protein from the vascular space into the airways. The recirculating volume of the constant pressure perfusion system was 90 ml; arterial and venous pressures were set at 8 and 0 cm H2O, respectively. The lungs were excised from the thoracic cavity and placed in a "pleural" bath (100 ml) filled with the same bovine serum albumin solution. The entire system was maintained at 37 °C in a water bath. The lungs were then instilled via the tracheal catheter with 5 ml of bovine serum albumin containing Evans blue dye-labeled albumin, 22Na+, and [3H]mannitol. Samples were taken from the instillate, perfusate, and bath solutions following a 10-min equilibration period and 60 min later. Absorbance at 620 nm (for Evans blue dye-albumin), fluorescence (excitation 487 nm; emission 520 nm; for FITC-albumin), and scintillation counting (for 22Na+ and [3H]mannitol) were measured in centrifuged samples from each compartment.

Calculations—The derivation of all equations involved in the mathematical model of edema clearance has previously been described in detail (4, 14). Concentration of Evans blue dye-albumin was used to estimate airspace volume. As virtually all Evans blue dye-albumin remains in the airspace, instillate volume (V) at a given time can be calculated from the increase in airspace protein concentration. The total unidirectional out-flux of Na+ from the alveolar space, a result of active transport and passive movement, was calculated from the rate of loss of 22Na+ from the airspaces. Passive sodium flux was calculated by subtracting the active sodium flux, calculated from the rate of net fluid clearance, from the total. Similarly, the unidirectional volume flux of mannitol was calculated from the rate of loss of [3H]mannitol from the airspaces. Albumin flux from the pulmonary circulation into the alveolar space was determined from the fraction of FITC-albumin that appears in the alveolar instillate during the experimental protocol. For comparison, fluxes are reported as volume fluxes (volume/time) by using the appropriate solute concentrations.

Perfusing with Low pO2 Levels—The perfusate and the instillate were bubbled with 95% oxygen, 5% CO2 and the final pO2 was measured using a NOVA Biomedical blood gas analyzer. pO2 levels were checked every 15 min during the 60-min experiment.

Exposure to Hypoxia—Animals were placed in a Ruskinn INVIVO2 400 Hypoxia chamber with a 12:12-h light-dark cycle. Food and water were available ad libitum. Oxygen and carbon dioxide levels in the chamber were continuously monitored while maintaining the chamber temperature between 18 and 22 °C.

Adenovirus Infection Protocol—Rats were anesthetized with 40 mg/kg Nembutal intraperitoneally and orally intubated with a 14-gauge plastic catheter prior to adenoviral infection (15). Three experimental groups were studied: Sham-surfactant (n = 6), Adnull (n = 8), and AdSOD2 (n = 10). A mixture of adenovirus in a 50% surfactant, 50% dialysis buffer vehicle was administered in four aliquots of 200 µl. Rats were rotated 90° between instillations given at 5-min intervals. Immediately before instillation, a forced exhalation was achieved by circumferential compression of the thorax. Compression was relinquished after endotracheal instillation of 200 µl of virus/vehicle followed by 800 µl of air. Rats were allowed to recover before extubation. Infected animals were maintained in separate isolator cages for 7 days prior to conducting experimental protocols.

Immunohistochemistry—Longitudinal sections from each fixed lung were embedded in paraffin for immunohistochemical analysis. Five-micrometer sections were deparaffinized in xylene and rehydrated through serial ethanol solutions. Using previously described methods, specimens were then treated with 3% H2O2 to reduce endogenous peroxidase activity prior to blocking of background (nonspecific) immunoreactivity with nonimmune goat serum. Primary antibody (1:500 dilution, Na,K-ATPase {alpha}1 Ab) was added for 1 ha t room temperature. Sections were washed with phosphate-buffered saline prior to the addition of goat anti-mouse secondary antibody. Immunodetection was accomplished via 3,39-diaminobenzidine staining for immunoperoxidase activity (Vector Elite ABC kit; Vector Laboratories, New Castle-upon-Tyne, UK). Sections were photographed (without counterstaining) using a digital photomicroscopy system (Spot II; Diagnostic Instruments, Sterling Heights, MI).

Whole Cell Lysate and Basolateral Cell Membrane Isolation and Western Blot Analysis—Approximately two millimeters of peripheral lung tissue was collected from each lobe and homogenized to obtain whole cell lysates and basolateral membranes as previously described (16, 17). Briefly, cell lysates were prepared by the addition of lysis buffer (20 mM Tris, pH 7.5, 150 mm NaCl, 1 mM EDTA, 1 mm EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mm Na3VO4, 1 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride) and centrifugation at 14,000 x g to eliminate the insoluble material. Basolateral membranes (BLM) were prepared using Percoll gradient centrifugation as described (17, 18). Briefly, peripheral lung tissue was homogenized in a buffer containing 300 mM mannitol in 12 mM Tris-HEPES, pH 7.6, and protease inhibitors as described above, then centrifuged twice to discard the nuclear and mitochondrial pellets. Supernatant was centrifuged at 48,000 x g for 30 min, and the BLM fraction was recovered after the membrane pellet was centrifuged in a 16% Percoll gradient at 48,000 x g for 30 min. Equal amount of proteins from cell lysates or BLMs were resolved by 10% SDS-PAGE and analyzed by immunoblotting with specific antibodies.

Na,K-ATPase Activity—Na,K-ATPase activity was determined by [32P]ATP hydrolysis as described before (17, 23). Briefly, basolateral cell membrane proteins isolated from the peripheral lung were placed on ice, and aliquots (~10 µg of protein) were transferred to the Na,K-ATPase assay medium (final volume 100 µl) containing NaCl 50 mM, KCl 5 mM, MgCl2 10 mM, EGTA 1 mM, Tris-HCl 50 mM, Na2ATP 7 mM, and [{gamma}-32P]ATP (specific activity 3000 Ci/mmol) in tracer amounts (3.3 nCi/µl). The samples were then incubated at 37 °C for 30 min, and the reaction was terminated by addition of 700 µl of trichloroacetic acid/charcoal (5/10% w/v) suspension and rapid cooling to 4 °C. After separating the charcoal phase (12,000 x g for 5 min) containing the unhydrolyzed nucleotide, the liberated 32P was counted in an aliquot (200 µl) from the supernatant. Na,K-ATPase activity was calculated as the difference between test samples (total ATPase activity) and samples assayed in the same medium but devoid of Na+ and K+ and in the presence of 4 mM ouabain (ouabain-insensitive ATPase activity). The results are expressed as mean nmol of Pi/mg of protein/h of triplicate measurements from three animals per group.

Data Analysis—When comparisons were made between two experimental groups, an unpaired Student's t test was used. When multiple comparisons were made, a one way analysis of variance and Duncan's means comparison test were used. Results were considered significant when p < 0.05.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Effect of Low pO2 on Alveolar Fluid Reabsorption in an ex Vivo Model—We determined the effect of low levels of oxygen on AFR by perfusing, in different experiments, decreasing levels of oxygen through the pulmonary circulation of the isolated, perfused rat lung. We observed that when pO2 levels were decreased from 100 mm Hg to either 85 or 60 mm Hg for 60 min there was a 60 and 40% reduction in AFR, respectively. When pO2 levels were reduced to 40 mm Hg for 60 min there was an even greater reduction in AFR (Fig. 1A).

The passive movement of small solutes ([3H]mannitol and 22Na+) and FITC-albumin across the epithelial barrier of the rat lung did not significantly change when pO2 levels were decreased in the pulmonary circulation of the isolated rat lungs as compared with control (data not shown), which validates the use of the model in assessing the role of low oxygen tension on AFR. The pulmonary circulation flow was measured periodically during the experiments and was similar (~12 ml/min) in all groups (data not shown).

The effect of low pO2 on the Na,K-ATPase was assessed in basolateral membranes isolated from the peripheral lung tissue, as we have previously described (16). The Na,K-ATPase activity decreased from 64.1 ± 9.5 to 17.5 ± 3.4 nmol of Pi/mg of protein/h in the basolateral membrane of rat lungs perfused with a pO2 of 40 mm Hg as compared with control (Fig. 1B). The decrease in activity paralleled a decrease in the Na,K-ATPase {alpha}1 protein abundance in the basolateral membrane isolated from rat lungs perfused with a pO2 of 40 mm Hg (Fig. 1C). There was no decrease in the abundance of Na,K-ATPase protein in total cell lysates (Fig. 1C) suggesting that there was endocytosis of Na,K-ATPase but no degradation of the protein.


Figure 1
View larger version (21K):
[in this window]
[in a new window]
  		FIGURE 1.
A, the effect of low levels of oxygen on AFR were determined by perfusing, in different experiments, decreasing levels of oxygen for 60 min through the pulmonary circulation of the isolated, perfused rat lung model. As pO2 levels were decreased from 120 to 40 mm Hg there was a concomitant decrease in alveolar fluid reabsorption. The bars represent mean ± S.D. *, p < 0.05 as compared with control; **, p < 0.001 as compared with control. B, Na,K-ATPase activity in BLM. BLMs were isolated from peripheral lung tissue of lungs perfused with pO2 40 mmHg for 60 min and compared with control lungs. Na,K-ATPase activity was measured by [{gamma}-32P]ATP hydrolysis in BLM incubated in presence or absence of ouabain. Each bar represents the mean ± S.D. of four determinations performed independently (separate BLM isolations) and in triplicate. +, p < 0.05. C, Na,K-ATPase {alpha}1 protein expression. Representative Western blot analyses for Na,K-ATPase {alpha}1 subunit protein abundance in BLMs (10 µg of protein/lane) and total lysates (lobes, 40 µg of protein/lane) isolated from peripheral lobes of lungs perfused with pO2 40 mmHg for 60 min and compared with control lungs.

 
Effect of Low pO2 on Alveolar Fluid Reabsorption in an in Vivo Model—We sought to determine whether there was a compensatory mechanism to prevent the decrease in AFR when animals (as opposed to isolated lungs) were exposed to low oxygen levels. Rats exposed to 8% oxygen for 24 h had significantly reduced rates of AFR as compared with normoxic rats (Fig. 2). Alveolar fluid reabsorption was inhibited even after 4 and 12 h of recovery in room air and returned to control levels only after 24 h of recovery in room air. The passive movement of small solutes ([3H]mannitol and 22Na+) and FITC-albumin across the epithelial barrier of the rat lung did not significantly change in the lungs of hypoxic rats (data not shown). There was increased cellularity in the lungs of rats exposed to 8% oxygen for 24 h as compared with normoxic control rats, but there were no significant structural changes in the hypoxic rat lungs (data not shown).

To determine whether the decrease in AFR was because of changes in the expression and function of the Na,K-ATPase, we isolated basolateral membranes from peripheral lung tissue of normoxic, hypoxic (8% O2, 24 h), and hypoxic recovery rats (8% O2, 24 h followed by 21% O2, 24 h). As shown in Fig. 3, A and B, there was a significant decrease in Na,K-ATPase activity and Na,K-ATPase {alpha}1 protein abundance in basolateral membrane of hypoxic rats as compared with normoxic control rats or hypoxic recovery rats, respectively. Importantly, there was a 60% decrease in Na,K-ATPase {alpha}1 protein abundance in total cell lysates of hypoxic rats, which was restored to normoxic control levels following 24 h of recovery in room air as determined by Western blot analysis (Fig. 3C). These results suggest that Na,K-ATPase is regulated during both short and long term hypoxia by altering the number of functional Na,K-ATPase molecules in the basolateral membrane. The apparent difference between acute exposure (see Fig. 1C) and prolonged exposure to low levels of oxygen (see Fig. 3C) is the abundance of Na,K-ATPase protein in total cell lysates. During prolonged exposure to hypoxia there is a decrease in Na,K-ATPase protein abundance. This decrease in protein abundance may be a reflection of increased degradation, presumably via the ubiquitin-proteasome pathway (28) or decreased transcription/translation of the protein.


Figure 2
View larger version (11K):
[in this window]
[in a new window]
  		FIGURE 2.
Alveolar fluid reabsorption was measured using the isolated perfused rat lung model in rats exposed to hypoxia (8% O2, 24 h) and then allowed to recover in 21% O2 for 4, 12, and 24 h. Results are expressed as means± S.E. of three to five experiments. The AFR was significantly decreased (+, p < 0.001) compared with that measured in normoxic control rats.

 
Effect of beta-Adrenergic Agonists on Alveolar Fluid Reabsorption in Hypoxic Rat Lungs—We have previously reported that stimulation of the beta-adrenergic receptor with isoproterenol (ISO) increases AFR in rat lungs (15, 20–22) via the translocation/recruitment of pre-existing Na,K-ATPase molecules from internal/endosomal compartments to the basolateral membrane (23). We sought to determine whether these "internalized" Na,K-ATPase molecules were available for recruitment to the basolateral membranes of rats exposed to 8% O2 for 24 h and then treated with ISO (10 µM, 60 min perfused through the pulmonary circulation) and whether this would restore AFR in hypoxic rat lungs. In normoxic control lungs, ISO (10–6 M) increased the rate of AFR by 100% (from 0.51 ± 0.05 to 1.05 ± 0.07 ml/h) and restored AFR to control levels in the lungs of hypoxic rats (from 0.02 ± 0.07 to 0.59 ± 0.03 ml/h) (Fig. 4A). The increase in AFR was associated with an increased Na,K-ATPase protein abundance in the basolateral membrane of ISO-treated hypoxic rat lungs as determined by Western blot analysis (Fig. 4B).

Mitochondrial ROS Mediate Hypoxia-induced Decrease in Alveolar Fluid Reabsorption—During hypoxia reactive oxygen species are initially produced as superoxide, which subsequently are converted to H2O2 in the mitochondria by superoxide dismutase (SOD2). To determine whether overexpression of the ROS scavenger SOD2 would prevent the hypoxia-induced decrease in AFR, spontaneously breathing rats were infected with an adenovirus expressing SOD2 (AdSOD2, 2–4 x 109 plaque-forming units) and compared with rats infected with a null virus (Adnull, 2–4 x 109 plaque-forming units) or sham-infected rats. Seven days postinfection, rats were exposed to normoxia or hypoxia (21 or 8% O2, respectively) for 24 h. Overexpression of SOD2 prevented the hypoxia-mediated decrease in AFR. Adnull- or sham-infected hypoxic rats had a significant decrease in AFR as compared with normoxic-control and AdSOD2 hypoxic rats (Fig. 5A). Lung homogenates were prepared, and proteins were separated by SDS-PAGE and immunoblotted with anti-SOD2. There was an abundant expression of SOD2 in AdSOD2-infected rats as compared with Adnull-infected rats (Fig. 5B). Additionally, Na,K-ATPase activity and protein abundance in basolateral membrane isolated from the peripheral lung tissue of AdSOD2-infected rats exposed to hypoxia was not different from normoxic control rats (Fig. 5, C and D).


Figure 3
View larger version (19K):
[in this window]
[in a new window]
  		FIGURE 3.
BLMs were isolated from peripheral lung tissue of rats exposed to 8% O2 for 24 h (hypoxia); rats exposed to 8% O2 for 24 h and allowed to recover in room air for 24 h (recovery) and compared with normoxic control lungs. A, Na,K-ATPase activity in BLM. Na,K-ATPase activity was measured by [{gamma}-32P]ATP hydrolysis in BLM incubated in presence or absence of ouabain. Each bar represents the mean ± S.D. of three to five determinations performed independently (separate BLM isolations) and in triplicate. *, p < 0.05. B, Na,K-ATPase {alpha}1 protein expression in BLM. Representative Western blot analyses for Na,K-ATPase {alpha}1 subunit protein abundance in BLMs (10 µg of protein/lane). Each bar represents the mean ± S.D. of three to five determinations performed independently (separate BLM isolations). *, p < 0.05. C, total lysates were isolated from peripheral lungs of control (CT), hypoxic (HYP), and recovery (REC) animals. A representative Western blot for Na,K-ATPase {alpha}1 subunit protein abundance in total lysates (45 µg of protein/lane) is shown.

 


Figure 4
View larger version (26K):
[in this window]
[in a new window]
  		FIGURE 4.
A, isoproterenol increased alveolar fluid reabsorption in rat lungs exposed to 8% O2 for 24 h (hypoxia); rats exposed to 8% O2 for 24 h and allowed to recover in room air for 24 h (recovery) as well as in normoxic control lungs. Bars represent means ± S.E. *, p < 0.001 versus control (CT); +p < 0.05 versus control. B, Na,K-ATPase {alpha}1 protein expression in BLM isolated from peripheral lung tissue. Representative Western blot analyses for Na,K-ATPase {alpha}1-subunit protein abundance in BLMs (10 µg of protein/lane). Each bar represents the mean ± S.D. of three to five determinations performed independently (separate BLM isolations). *, p < 0.05. HYP, hypoxia; REC, recovery.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
This study demonstrates that hypoxia decreases AFR, in both an in vivo and ex vivo model of exposure to low oxygen levels, which is associated with a decrease in Na,K-ATPase activity. These functional changes are associated with a significant decrease in Na,K-ATPase protein expression in total cell lysates, as well as in the basolateral membrane prepared from peripheral lung tissue. The hypoxia-mediated decrease in AFR and protein expression could be abrogated by treatment with either isoproterenol or the overexpression of SOD2.

The present study also provides evidence that the effects of hypoxia on alveolar ion transport proteins (10–12) is not a tissue culture phenomenon but also occurs in vivo. The regulation of alveolar transport proteins is vital in the maintenance of alveolar fluid balance in patients (24). A reduction in the number of copies of these transporters could reduce the capacity of alveolar ion transport. Subsequently, the reabsorption of fluid filtered into alveolar space might be reduced, which would have significant deleterious effects (25).

Several studies have reported that exposure to hypoxia can reduce the ability of the lung to clear liquid from the air spaces, although the mechanisms by which the impairment in alveolar fluid reabsorption has not been fully elucidated (9, 13, 26, 27). Vivona et al. (9) exposed rats to hypoxia and observed a significant decrease in alveolar fluid reabsorption with no change in expression of Na,K-ATPase protein prepared from crude cell lysates. In another study, animals exposed to hypoxia had a decrease in nasal potential difference that was associated with a decrease in Na,K-ATPase activity, but no change in Na,K-ATPase protein expression (13). In vitro studies of alveolar epithelial cells exposed to hypoxia clearly demonstrate a decrease in Na,K-ATPase activity that is associated with the endocytosis of the Na,K-ATPase from the basolateral membrane (12). Dada et al. (12) reported that during exposure to hypoxia, mitochondrial ROS activate PKC-{zeta}, which phosphorylates Na,K-ATPase and triggers it for endocytosis. This results in fewer Na,K-ATPase pumps at the plasma membrane and decreased Na,K-ATPase activity.


Figure 5
View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 5.
Rats were infected with AdSOD2 and compared with sham- and Adnull-infected rats. Seven days following infection the rats were exposed to either 21 or 8% O2 for 24 h. A, AFR was significantly decreased in hypoxic sham- and Adnull-infected rats, as compared with normoxic controls. AFR was unchanged in AdMnSOD2-infected rats exposed to hypoxia as compared with normoxic controls. Results are expressed as means ± S.E. of three to six experiments. *, p < 0.001. B, a representative Western blot of the SOD2 protein abundance in lung tissue from Adnull- and AdSOD2-infected rats. Each lane represents a single animal. C, Na,K-ATPase {alpha}1 protein expression in BLM isolated from peripheral lung tissue of Adnull- and AdMnSOD-treated animals (upper panel). Representative Western blot analyses for Na,K-ATPase {alpha}1 subunit protein abundance in BLMs (7.5 µg of protein/lane). Each bar represents the mean ± S.D. of three to five determinations performed independently (separate BLM isolations). *, p < 0.05. D, Na,K-ATPase activity in BLM isolated from peripheral lung tissue of Adnull- and AdMnSOD-treated animals. Na,K-ATPase activity was measured by [{gamma}-32P]ATP hydrolysis in BLM incubated in presence or absence of ouabain. Each bar represents the mean ± S.D. of three to five determinations performed independently (separate BLM isolations) and in triplicate. *, p < 0.05.

 
We report that in both the ex vivo and in vivo models of hypoxia, low pO2 levels caused a decrease in the Na,K-ATPase activity (Figs. 1A and 3A, respectively), which was associated with a decrease in protein abundance at the basolateral membrane in both models (Figs. 1C and 3B). However, there was no change in the Na,K-ATPase protein abundance in total lysates prepared from the lungs exposed to short term hypoxia (pO2 = 40 mm Hg, 60 min) (Fig. 1C), whereas there was a significant decrease in Na,K-ATPase protein abundance in total lysates prepared from lungs exposed to long term hypoxia (8% oxygen, 24 h) (Fig. 3C). These results suggest that Na,K-ATPase activity is regulated during hypoxia, in both short and long term hypoxia models, by altering the number of functional Na,K-ATPase molecules in the basolateral membrane through the endocytosis of Na,K-ATPase. Prolonged exposure to low levels of oxygen (see Fig. 3C) results in a decrease in the Na,K-ATPase protein abundance, which may reflect the degradation of Na,K-ATPase, presumably via the ubiquitin-proteasome pathway (28). Alternatively, hypoxia could affect the transcription and/or translation of Na,K-ATPase proteins thus altering the levels of the protein abundance in total cell lysates. However, steady-state levels of Na,K-ATPase {alpha}1 mRNA were either unchanged following exposure to hypoxia (9, 13) or significantly decreased during exposure to hypoxia (11, 29).

The decreased abundance of Na,K-ATPase molecules in the basolateral membrane was associated with decreased AFR in both the in vivo and ex vivo models of hypoxia. Conversely, when AFR was restored to control levels within 24 h of recovery in room air (Fig. 2A), this was associated with parallel increases in Na,K-ATPase activity and protein abundance in the basolateral membrane and in total lysates (Fig. 3). We speculate that AFR could be restored by increasing the abundance of the Na,K-ATPase molecules at the basolateral membrane by 1) increased rates of transcription and/or translation of Na,K-ATPase; 2) recruitment/translocation of internally stored functional Na,K-ATPase molecules. It has been previously reported that steady-state levels of Na,K-ATPase {alpha}1 mRNA were either unchanged following exposure to hypoxia (9, 13) or significantly decreased during exposure to hypoxia and then increased during the reoxygenation phase (11, 29). Our data suggests that extended exposure to hypoxia results in a decrease in Na,K-ATPase protein abundance, which returns to normal levels upon reoxygenation (Fig. 3C). The disparity in these reports will require additional investigations to determine the role of transcription and/or translational regulation of the Na,K-ATPase during exposure to hypoxia.

We have previously reported that catecholamines increase AFR in normal and injured rat lungs (4, 8, 20–22, 30) and that catecholamine-mediated increases in AFR are dependent upon expression levels of Na,K-ATPase proteins in the basolateral membrane. In the present study, we examined whether the beta-adrenergic agonist ISO when perfused through the pulmonary circulation could improve active Na+ transport and AFR in hypoxic rats. The data show that ISO restored the ability of the lung to clear edema in rats exposed to hypoxia for 24 h (Fig. 4A). We reason that the reduced capacity of the lung to clear edema in hypoxic animals was probably not so severe as to preclude the ability of the lung to respond to beta-adrenergic stimulation. Further support for this notion is the data in Fig. 4B showing that ISO increased the Na,K-ATPase protein abundance in the basolateral membrane in hypoxic lungs. There are several mechanisms by which ISO may increase the number of Na,K-ATPase molecules in the BLM, including changes in the rate of Na,K-ATPase protein synthesis. In fact, we have previously demonstrated that activation of the beta-adrenergic receptor was associated with increased Na,K-ATPase abundance and enzymatic activity (19, 22, 23). However, translational regulation of the Na,K-ATPase via beta-adrenergic receptor agonist generally occurs over a period >24 h, much longer than the 60-min time course of our experimental conditions. Therefore, we reasoned that Na,K pumps are stored in intracellular compartments and can be recruited for insertion in the basolateral membrane. As shown in Fig. 4, ISO-treated lungs had increased Na,K-ATPase protein abundance in the BLM of both normoxic and hypoxic rat lungs. These results suggest that ISO can be used to increase the Na,K-ATPase and restore AFR in hypoxic rat lungs (Fig. 4).

Hypoxia has been shown to increase the generation of mitochondrial ROS at the semiubiquinone site, where an electron can be transferred to O2 to produce superoxide (Formula). Superoxide generated within the mitochondrial matrix is converted to H2O2 by manganese SOD (SOD2), and H2O2 can then be degraded by mitochondrial glutathione peroxidase. In the present study, we infected rats with adenoviral vectors expressing SOD2 (AdSOD2). Animals treated with SOD2 adenoviral vectors had increased expression levels of SOD2 as demonstrated in Fig. 5B. We hypothesized that overexpression of SOD2 would detoxify ROS generated within the mitochondria and prevent the down-regulation of the Na,K-ATPase expression and AFR. Indeed, in animals that were infected with AdSOD2 and then subsequently exposed to hypoxia there was no change in AFR as compared with normoxic control animals. Further, the Na,K-ATPase activity and expression of the Na,K-ATPase {alpha}1 protein in the basolateral membrane of AdSOD2-infected hypoxic animals was also unchanged.

In summary, we provide evidence that beta-adrenergic receptor agonists improve alveolar fluid reabsorption in hypoxia-exposed lungs. Increased rates of AFR by beta-adrenergic stimulation were probably mediated by the recruitment and translocation of Na,K-ATPase from intracellular pools to the cell plasma membrane in alveolar epithelium. The overexpression of the ROS scavenger SOD2 had a protective effect on animals that were subsequently exposed to low levels of oxygen, probably by preventing ROS-mediated activation of signal transduction cascades. The outcomes of patients with acute lung injury and pulmonary edema are related to the ability of the lung to clear edema. Conceivably, beta-adrenergic agonists and/or ROS scavengers could be utilized as a therapeutic strategy to improve functional recovery of patients prone to high altitude pulmonary edema and patients with acute hypoxemic respiratory failure and pulmonary edema.


   FOOTNOTES
 
* This work was supported by Grants PO1-HL71643, RO1-HL079190, and RO1-HL48129 from the National Institutes of Health and by the Department of Veteran Affairs (VA-MREP). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: Northwestern University Medical School, Pulmonary and Critical Care Medicine, 240 E. Huron, McGaw M328, Chicago, IL 60611. Tel.: 312-503-1648; Fax: 312-908-4650; E-mail: kridge{at}northwestern.edu.

2 The abbreviations used are: AFR, alveolar fluid reabsorption; FITC, fluorescein isothiocyanate; BLM, basolateral membrane; ISO, isoproterenol; ROS, reactive oxygen species; SOD2, superoxide dismutase. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Sartori, C., Allemann, Y., Duplain, H., Lepori, M., Egli, M., Lipp, E., Hutter, D., Turini, P., Hugli, O., Cook, S., Nicod, P., and Scherrer, U. (2002) N. Engl. J. Med. 346, 1631–1636[Abstract/Free Full Text]
  2. Eaton, D. C., Chen, J., Ramosevac, S., Matalon, S., and Jain, L. (2004) Proc. Am. Thorac. Soc. 1, 10–16[Abstract/Free Full Text]
  3. Matalon, S., Lazrak, A., Jain, L., and Eaton, D. C. (2002) J. Appl. Physiol. 93, 1852–1859[Abstract/Free Full Text]
  4. Azzam, Z. S., Adir, Y., Crespo, A., Comellas, A., Lecuona, E., Dada, L. A., Krivoy, N., Rutschman, D. H., Sznajder, J. I., and Ridge, K. M. (2004) Am. J. Respir. Crit. Care Med. 170, 730–736[Abstract/Free Full Text]
  5. Ware, L. B., and Matthay, M. A. (2000) N. Engl. J Med. 342, 1334–1349[Free Full Text]
  6. Dumasius, V., Sznajder, J. I., Azzam, Z. S., Boja, J., Mutlu, G. M., Maron, M. B., and Factor, P. (2001) Circ. Res. 89, 907–914[Abstract/Free Full Text]
  7. Saldias, F. J., Azzam, Z. S., Ridge, K. M., Yeldandi, A., Rutschman, D. H., Schraufnagel, D., and Sznajder, J. I. (2001) Am. J. Physiol. 281, L591–L597
  8. Suzuki, S., Noda, M., Sugita, M., Ono, S., Koike, K., and Fujimura, S. (1999) J. Appl. Physiol. 87, 962–968[Abstract/Free Full Text]
  9. Vivona, M. L., Matthay, M., Chabaud, M. B., Friedlander, G., and Clerici, C. (2001) Am. J. Resp. Cell Mol. Biol. 25, 554–561[Abstract/Free Full Text]
  10. Planes, C., Friedlander, G., Loiseau, A., Amiel, C., and Clerici, C. (1996) Am. J. Physiol. 271, L70–L78
  11. Wodopia, R., Ko, H. S., Billian, J., Wiesner, R., Bartsch, P., and Mairbaurl, H. (2000) Am. J. Physiol. 279, L1110–L1119
  12. Dada, L. A., Chandel, N. S., Ridge, K. M., Pedemonte, C., Bertorello, A. M., and Sznajder, J. I. (2003) J. Clin. Investig. 111, 1057–1064[CrossRef][Medline] [Order article via Infotrieve]
  13. Carpenter, T. C., Schomberg, S., Nichols, C., Stenmark, K. R., and Weil, J. V. (2003) Am. J. Physiol. 284, L77–L83
  14. Rutschman, D. H., Olivera, W., and Sznajder, J. I. (1993) J. Appl. Physiol. 75, 1574–1580[Abstract/Free Full Text]
  15. Ridge, K. M., Olivera, W. G., Saldias, F., Azzam, Z., Horowitz, S., Rutschman, D. H., Dumasius, V., Factor, P., and Sznajder, J. I. (2003) Circ. Res. 92, 453–460[Abstract/Free Full Text]
  16. Azzam, Z. S., Dumasius, V., Saldias, F. J., Adir, Y., Sznajder, J. I., and Factor, P. (2002) Circulation 105, 497–501[Abstract/Free Full Text]
  17. Ridge, K., Dada, L., Lecuona, E., Bertorello, A., Katz, A., Mochly-Rosen, D., and Sznajder, J. I. (2002) Mol. Biol. Cell 13, 1381–1389[Abstract/Free Full Text]
  18. Barnard, M. L., Ridge, K. M., Saldias, F., Friedman, E., Gare, M., Guerrero, C., Lecuona, E., Bertorello, A. M., Katz, A. I., and Sznajder, J. I. (1999) Am. J. Resp. Crit. Care Med. 160, 982–986[Abstract/Free Full Text]
  19. Pesce, L., Comellas, A., and Sznajder, J. I. (2003) Am. J. Physiol. 285, L802–L807
  20. Saldias, F., Lecuona, E., Friedman, E., Barnard, M. L., Ridge, K. M., and Sznajder, J. I. (1998) Am. J. Physiol. 274, L694–L701
  21. Saldias, F. J., Comellas, A., Ridge, K. M., Lecuona, E., and Sznajder, J. I. (1999) J. Appl. Physiol. 87, 30–35[Abstract/Free Full Text]
  22. Saldias, F. J., Lecuona, E., Comellas, A. P., Ridge, K. M., Rutschman, D. H., and Sznajder, J. I. (2000) Am. J. Resp. Crit. Care Med. 162, 282–287[Abstract/Free Full Text]
  23. Bertorello, A. M., Ridge, K. M., Chibalin, A. V., Katz, A. I., and Sznajder, J. I. (1999) Am. J. Physiol. 276, L20–L27
  24. Ware, L. B., and Matthay, M. (2001) Am. J. Resp. Crit. Care Med. 163, 1376–1383[Abstract/Free Full Text]
  25. Sznajder, J. I. (2001) Am. J. Resp. Cell Mol. Biol. 163, 1293–1294
  26. Clerici, C., and Matthay, M. A. (2000) J. Appl. Physiol. 88, 1890–1896[Abstract/Free Full Text]
  27. Sartori, C., Duplain, H., Lepori, M., Egli, M., Maggiorini, M., Nicod, P., and Scherrer, U. (2004) Eur. Respir. J. 23, 916–920[Abstract/Free Full Text]
  28. Comellas, A. P., Dada, L. A., Lecuona, E., Pesce, L. M., Chandel, N. S., Quesada, N., Budinger, G. R. S., Strous, G. J., Ciechanover, A., and Sznajder, J. I. (April 13, 2006) Circ. Res. published ahead of print PMID: 16614303, 2006
  29. Planes, C., Escoubet, B., Blot-Chabaud, M., Friedlander, G., Farman, N., and Clerici, C. (1997) Am. J. Respir. Cell Mol. Biol. 17, 508–518[Abstract/Free Full Text]
  30. Azzam, Z. S., Saldias, F., Comellas, A., Ridge, K., Rutschman, D., and Sznajder, J. I. (2001) J. Appl. Physiol. 90, 1088–1094[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Adir, L. C. Welch, V. Dumasius, P. Factor, J. I. Sznajder, and K. M. Ridge
Overexpression of the Na-K-ATPase {alpha}2-subunit improves lung liquid clearance during ventilation-induced lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1233 - L1237.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. Zhou, L. A. Dada, and J. I. Sznajder
Regulation of alveolar epithelial function by hypoxia
Eur. Respir. J., May 1, 2008; 31(5): 1107 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
G. Zhou, L. A. Dada, N. S. Chandel, K. Iwai, E. Lecuona, A. Ciechanover, and J. I. Sznajder
Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein
FASEB J, May 1, 2008; 22(5): 1335 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
G. M. Mutlu and P. Factor
Alveolar Epithelial 2-Adrenergic Receptors
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 127 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. Chen, E. Lecuona, A. Briva, L. C. Welch, and J. I. Sznajder
Carbonic Anhydrase II and Alveolar Fluid Reabsorption during Hypercapnia
Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 32 - 37.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Physiol.Home page
I. Yu. Petrushanko, N. B. Bogdanov, N. Lapina, A. A. Boldyrev, M. Gassmann, and A. Yu. Bogdanova
Oxygen-induced Regulation of Na/K ATPase in Cerebellar Granule Cells
J. Gen. Physiol., September 24, 2007; 130(4): 389 - 398.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
L. A. Dada, E. Novoa, E. Lecuona, H. Sun, and J. I. Sznajder
Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells
J. Cell Sci., July 1, 2007; 120(13): 2214 - 2222.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/29/19892    most recent
M602064200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Litvan, J.
Right arrow Articles by Ridge, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litvan, J.
Right arrow Articles by Ridge, K. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.